Nivea launches its Cellular Epigenetics anti-ageing skincare at €17.99 with Faustine Bollaert
What if ageing could finally become a conscious choice rather than a losing battle? That is precisely the question Nivea is asking with its new Cellular Epigenetics range, launched in 2026 to work with skin over time rather than trying to erase every trace the years leave behind.
Faustine Bollaert and Nivea: a brand ambassador who changes the conversation
To front the launch, the German brand chose Faustine Bollaert, journalist and television presenter. The choice is far from accidental. She embodies a confident, unforced kind of beauty, far removed from the promise of youth at any cost. Her position is clear: she does not expect her skincare to make her look 20 again, but to help her thrive fully at 47. In her view, this range optimises her skin while remaining genuinely kind to it.
That message taps into a growing shift in consumer expectations. The anti-ageing market is undergoing a profound transformation. The all-out war on wrinkles is gradually giving way to a pro-age vision centred on ageing well. Nivea is firmly part of this movement, offering a routine built for the long term.
What the Cellular Epigenetics routine actually contains
The range is rooted in an approach inspired by longevity science. Its name, Cellular Epigenetics, reflects that ambition: to work deep within the skin to preserve its youthfulness over time, not just on the surface.
- EPICELLINE®, the formula’s key ingredient, is present across the entire routine
- Three types of hyaluronic acid are combined for targeted action
- An SPF30 sun protection is built into the day cream
- Four areas of the face receive particular attention: cheeks, forehead, contours and expression lines
- The range is designed for all skin types
The routine is designed to slot easily into everyday life. Nivea has made accessibility a priority, both in terms of use and price.
The day cream at €17.99: what it promises
At the heart of the range, the Cellular Epigenetics Youth Day Cream SPF30 is priced at €17.99. It combines EPICELLINE®, three forms of hyaluronic acid and SPF30 protection to address both the visible signs of time and daily skin protection in a single step.
The results shared by the brand are specific: 93% of women who used this cream report visibly younger-looking skin. That figure, drawn from Nivea‘s own data, captures the range’s central promise: act today to protect the skin of tomorrow.
This cream sits within a complete routine built around the same logic. Every product in the range shares this philosophy of gradual, clinically proven care designed to last.
A skincare philosophy that goes beyond the product itself
Behind Cellular Epigenetics, Nivea is championing a broader vision. The brand, known for decades for its iconic blue tin, is not turning its back on its nourishing heritage. It is enriching it with a scientific dimension and an ethical stance on ageing.
Because the real shift is not only in the formula. It is in the conversation. Offering clinically proven, easy-to-adopt and financially accessible skincare means making skin longevity a reality for everyone. The brand is no longer promising to mask the passage of time, but to accompany each person’s skin at its own pace.
